Sideroblastic anemia

Blood and Bone Marrow Pathology

Volumn , Issue , 2011, Pages 225-233

  May, A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870793019     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3147-2.00014-6     Document Type: Chapter

References (55)

1. Bessis MC, Breton-Gorius J Ferritin and ferruginous micelles in normal erythroblasts and hypochromic hypersideremic anemias. Blood 1959, 14:423-432.
2. Wickramasinghe SN, Fulker MJ, Losowsky MS, Hall R Microspectrophotometric and electron microscopic studies of bone marrow in hereditary sideroblastic anaemia. Acta Haematol 1971, 45:236-244.
3. Cazzola M, Invernizzi R, Bergamaschi G Mitochondrial ferritin expression in erythroid cells from patients with SA. Blood 2003, 101:1996-2000.
4. Bottomley SS Sideroblastic anemias. Wintrobe's Clinical Hematology 2008, 835-855. Lippincott Williams & Wilkins, Philadelphia. 12th ed. J.P. Greer, J. Foerster, G.M. Rodgers .
5. Bergmann AK, Campagna DR, McLoughlin EM, et al. Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations. Pediatr Blood Cancer 2010, 54:273-278.
6. Ferreira GC, Gong J 5-Aminolevulinate synthase and the first step of heme biosynthesis. J Bioenerg Biomembr 1995, 27:151-159.
7. Harris JW, Whittington RM, Weisman R, Horrigan DL Pyridoxine responsive anemia in the human adult. Proc Soc Exp Biol Med 1956, 91:427-432.
8. May A, Bishop DF The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia. Haematologica 1998, 83:56-70.
9. Cazzola M, May A, Bergamaschi G, et al. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females. Blood 2000, 96:4363-4365.
10. Aivado M, Gatterman N, Rong A, et al. X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns. Blood Cells Mol Dis 2006, 37:40-45.
11. Anderson KE, Sassa S, Bishop DF, Desnick RJ Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. The Metabolic and Molecular Bases of Inherited Disease 2001, Vol 2:2991-3062. McGraw-Hill, New York, NY. 8th ed.
12. Peto TE, Pippard MJ, Weatherall DJ Iron overload in mild sideroblastic anaemias. Lancet 1983, 1:375-378.
13. Cotter PD, May A, Li L, et al. Four new mutations in the erythroid-specific 5-aminolevulinate synthase gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis. Blood 1999, 93:1757-1769.
14. Cazzola M, May A, Bergamaschi G, et al. Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation. Blood 2002, 100:4236-4238.
15. Cotter PD, May A, Fitzsimons EJ, et al. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid δ-aminolevulinate synthase gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts. J Clin Invest 1995, 96:2090-2096.
16. Shoolingin-Jordan PM, Al-Daihan S, Alexeev D, et al. 5-Aminolevulinic acid synthase: mechanism, mutations and medicine. Biochim Biophys Acta 2003, 1647:361-366.
17. Astner I, Schulze JO, Van Den Hevel J, et al. Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans. EMBO J 2005, 24:3166-3177.
18. Furuyama K, Fujita H, Nagai T, et al. Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene. Blood 1997, 90:822-830.
19. Whatley SD, Ducamp S, Gouya L, et al. C-terminal deletions in the ALAS2 gene lead to gain of function and cause a previously undefined type of human porphyria, X-linked dominant protoporphyria, without anemia or iron overload. Am J Hum Genet 2008, 83:408-414.
20. Cortesao E, Vidan J, Pereira J, et al. Onset of X-linked sideroblastic anemia in the fourth decade. Haematologica 2004, 89:1261-1263.
21. Pagon RA, Bird TD, Detter JC, Pierce I Hereditary sideroblastic anaemia and ataxia: an X linked recessive disorder. J Med Genet 1985, 22:267-273.
22. Allikmets R, Raskind WH, Hutchinson A, et al. Mutation of a putative mitochondrial iron transporter gene (ABCB7) in X-linked sideroblastic anemia and ataxia . Hum Mol Genet 1999, 8:743-749.
23. Bekri S, Kispal G, Lange H, et al. Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. Blood 2000, 96:3256-3264.
24. Maguire A, Hellier K, Hammans S, May A X-linked cerebellar ataxia and sideroblastic anaemia associated with a missense mutation in the ABC7 gene predicting V411L. Br J Haematol 2001, 115:910-917.
25. Cavadini P, Biasiotto G, Poli M, et al. RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. Blood 2007, 109:3552-3559.
26. Hellier KD, Hatchwell E, Duncombe AS, et al. X-linked sideroblastic anaemia with ataxia: another mitochondrial disease?. J Neurol Neurosurg Psychiatry 2001, 70:65-69.
27. Lill R Function and biogenesis of iron-sulphur proteins. Nature 2009, 460:831-838.
28. Dandekar T, Stripecke R, Gray NK, et al. Identification of a novel iron-responsive element in murine and human erythroid δ-aminolevulinic acid synthase mRNA. EMBO J 1991, 10:1903-1909.
29. Guernsey DL, Jiang H, Campagna DR, et al. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet 2009, 41:651-653.
30. Camaschella C, Campanella A, De Falco L, et al. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 2007, 110:1353-1358.
31. Wingert RA, Galloway JL, Barut B, et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 2005, 436:1035-1039.
32. Inbal A, Avissar N, Shaklai M, et al. Myopathy, lactic acidosis, and sideroblastic anemia: a new syndrome. Am J Med Genet 1995, 55:372-378.
33. Casas KA, Fischel-Ghodsian N Mitochondrial myopathy and sideroblastic anaemia. Am J Med Genet 2004, 125A:201-204.
34. Fernandez-Vizarra E, Berardinelli A, Valente L, et al. Nonsense mutation in pseudouridylate synthase 1 in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia . J Med Genet 2007, 44:173-180.
35. Riley LG, Cooper S, Hickey P, et al. Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia-MLASA syndrome. Am J Hum Genet 2010, 87:52-59.
36. Rogers LE, Porter S, Sidbury JB Thiamine-responsive megaloblastic anemia. J Pediatr 1969, 74:494-504.
37. Bergmann AK, Sahai I, Falcone JF, et al. Thiamine-responsive megaloblastic anemia: identification of novel heterozygotes and mutation update. J Pediatr 2009, 155:888-892.
38. Fleming JC, Tartaglini E, Steinkamp MP, et al. The gene mutated in thiamine-responsive anemia with diabetes and deafness encodes a functional thiamine transporter. Nat Genet 1999, 22:305-308.
39. Neufeld EJ, Fleming JC, Tartaglini E, Steinkamp MP Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. Blood Cells Mol Dis 2001, 27:135-138.
40. Ricketts CJ, Minton JA, Samuel J, et al. Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. Acta Paediatr 2006, 95:99-104.
41. van Waveren Hogervorst GD, van Roermund HPC, Snijders PJ Hereditary sideroblastic anaemia and autosomal inheritance of erythrocyte dimorphism in a Dutch family. Eur J Haematol 1987, 38:405-409.
42. Tuckfield A, Ratnaike S, Hussein S, Metz J A novel form of hereditary sideroblastic anaemia with macrocytosis. Br J Haematol 1997, 97:279-285.
43. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979, 95:976-984.
44. Rotig A, Cormier V, Blanche S, et al. Pearson's marrow-pancreas syndrome: a multisystem mitochondrial disorder in infancy. J Clin Invest 1990, 86:1601-1608.
45. McShane MA, Hammans SR, Sweeney M, et al. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 1991, 48:39-42.
46. Domingo-Claros A, Alonso E, Banda Ed Ede L Schizophrenia and refractory anaemia with ring sideroblasts. Br J Haematol 2004, 125:543.
47. Gill H, Yip T, Lo W-K Anemia in a patient newly transferred from peritoneal dialysis to hemodialysis. Am J Kid Dis 2010, 56:xxxvii-xxxvix.
48. Vardiman JW, Harris NL, Brunning RD The World Health Organization classification of the myeloid neoplasms. Blood 2002, 100:2292-2302.
49. Cazzola M, Malcovati L Myelodysplastic syndromes - coping with ineffective hematopoiesis. New Engl J Med 2005, 352:536-538.
50. Malcovati L, Germing U, Kuendgen A, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007, 25:3503-3510.
51. Dewald GW, Brecher M, Travis LB, Stupca PJ Twenty-six patients with hematologic disorders and X chromosome abnormalities. Frequent idic chromosomes and Xq13 anomalies associated with pathologic ringed sideroblasts. Cancer Genet Cytogenet 1989, 42:173-185.
52. Bowen D, Culligan D, Jowitt S, et al. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol 2003, 120:187-200.
53. Hellström-Lindberg E, Malcovati L Supportive care, growth factors, and new therapies in myelodysplastic syndromes. Blood Rev 2008, 22:75-91.
54. Boultwood J, Pellagatti A, Nikpour M, et al. The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS One 2008, 3:e1970.
55. Malcovati L, Della Porta MG, Pietra D, et al. Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Blood 2009, 114:3538-3545.